The Service also includes a cosmetic surgery unit. The Ocular Oncology Service , one of the largest in the world, serves an international patient population. Its physicians are leaders in the diagnosis and treatment of ocular oncology, particularly melanoma and retinoblastoma, and have developed new techniques to save eyes that, in the past, it would have been necessary to remove. The Pathology Service is the backbone of teaching at Wills. It conducts ongoing research into the broad spectrum of ocular diseases.
Physicians also perform cataract surgery on infants as early as a few weeks old.
A pediatric contact lens service at Wills fits and stocks lenses exclusively for children. The Retina Service was the first subspecialty service at Wills. Today, an average of 15,000 patients are diagnosed and treated here each year. All vitreoretinal diseases are treated at Wills, including macular degeneration, diabetic retinopathy, uveitis, and retinitis pigmentosa. The Lab uses advanced computerized techniques to discover the earliest signs of glaucoma in suspected patients and to chart progression of the condition in patients with diagnosed glaucoma.